Pulmonary embolism (PE) remains a major contributor to global disease burden. Risk-
adapted treatment and follow-up contributes to a favorable outcome. Age-adjusted cutoff …

Venous thromboembolism (VTE) is one of the three most common cardiovascular diseases
in the United States. It is also a leading cause of death among patients with cancer. Cancer …

Background Clear guidelines for the investigation of occult malignancy after unprovoked
venous thromboembolism are not yet available. 18 F-fluorodeoxyglucose (18 F-FDG) …

PTTM is increasingly recognized as an important cause of pulmonary hypertension, often in
patients presenting with new-onset pulmonary hypertension and as yet undiagnosed …

Patients with unprovoked venous thromboembolism (VTE) may harbor occult cancer.
Whether an extensive diagnostic work-up for cancer has additional value over a more …

Risk factors predictive of occult cancer detection in patients with a first unprovoked
symptomatic venous thromboembolism (VTE) are unknown. Cox proportional hazard …

Atrial fibrillation (AF) affects more than 33 million people worldwide. 1 The prevalence in
high-income countries is 1% to 4% but increases to more than 13% of persons older than 80 …

Background Unprovoked venous thromboembolism (VTE) is related to a higher incidence of
occult cancer. D-dimer is clinically used for screening VTE, and has often been shown to be …

The HYPERCAN is a prospective observational Italian multicentre study started in 2012,
structured in two main projects (ie Projects A and B) that involve both healthy subjects and …

Essentials• A relationship between unprovoked venous thromboembolism (VTE) and cancer
risk was investigated.• We collected 27 751 VTE patients and compared them with 110 409 …